Search - tctmd.com

Displaying 1 - 20 of 1009

Sort: Relevancy | Date

Presentation ACC 2025

Two-year Outcomes Of Transcatheter Tricuspid Valve Edge-to-Edge Repair For Tricuspid Regurgitation: The TRILUMINATE Pivotal Trial

Presenter: Saibal Kar

March 30, 2025

Presentation Miami Valves 2025

Tricuspid valve replacement in a patient with a torn leaflet

Presenter: Joerg Kellermair

January 30, 2025

Presentation Miami Valves 2025

Percutaneous Tricuspid Valve Intervention (s)

Presenter: Christopher Hawk

January 30, 2025

Presentation Miami Valves 2025

Heterotopic Cross-Caval Tricuspid Valve Replacement- New Innovations

Presenter: Santiago Garcia

January 30, 2025

Presentation Controversies and Advances 2025

FDA Approval for TTVI

Presenter: David J. Cohen

January 30, 2025

Presentation Cardiovascular Interventions 2024

Transcatheter Tricuspid Replacement or Repair: Matching the Device with the Patient

Presenter: Matthew J. Price

November 11, 2024

Presentation TCT 2024

Patient Considerations

Presenter: Firas Zahr

October 30, 2024

Presentation TCT 2024

Imaging Considerations

Presenter: Rebecca Hahn

October 30, 2024

Presentation TCT 2024

Who to Treat With TTVI?

Presenter: Suzanne Arnold

October 30, 2024

Presentation TCT 2024

How to Manage After TTVI?

Presenter: Susheel Kodali

October 30, 2024

Presentation TCT 2024

Patient-Reported Outcomes are a True Measure of TTVI Value

Presenter: John Spertus

October 30, 2024

Presentation TCT 2024

CV Event Reduction is the Essential Criterion for Implementing New Device Therapies

Presenter: Ori Ben-Yehuda

October 30, 2024

Presentation TCT 2024

TRISCEND II Trial: Transcatheter Valve Replacement vs. Optimal Medical Therapy for Severe Tricuspid Regurgitation

Presenter: Susheel Kodali

October 30, 2024

Presentation TCT 2024

Transcatheter Tricuspid Valve Replacement - Lessons Learned From TRISCEND II

Presenter: Charles Davidson

October 30, 2024

Presentation TCT 2024

Transcatheter Tricuspid Edge-To-Edge-Repair – Updates from TRILUMINATE and TRI-FR

Presenter: Paul Sorajja

October 30, 2024

Presentation TCT 2024

Real World TTVI Registries vs. Randomized Trials: Are the Outcomes Aligned?

Presenter: Brian Whisenant

October 30, 2024

Presentation TCT 2024

TCT 984: Management of Right-Sided Vegetations With the AngioVac System: Single-Center Outcomes

Presenter: Alexandra Lackey

October 30, 2024

Presentation TCT 2024

TCT 983: Innovative Approach to Right Sided Endocarditis

Presenter: Bahjat Aladili

October 30, 2024

Presentation TCT 2024

TCT 982: The Safety of Catheter Aspiration of Tricuspid Valve Endocarditis Versus Open Surgery

Presenter: Rohan A Shah

October 30, 2024

Presentation TCT 2024

How to Interpret Patient Reported Outcomes (PROs): Lessons from the Regulatory Approval Trials in TTVI

Presenter: Suzanne Arnold

October 30, 2024

Advertisement

Two-year Outcomes Of Transcatheter Tricuspid Valve Edge-to-Edge Repair For Tricuspid Regurgitation: The TRILUMINATE Pivotal Trial

Tricuspid valve replacement in a patient with a torn leaflet

Percutaneous Tricuspid Valve Intervention (s)

Heterotopic Cross-Caval Tricuspid Valve Replacement- New Innovations

FDA Approval for TTVI

Transcatheter Tricuspid Replacement or Repair: Matching the Device with the Patient

Patient Considerations

Imaging Considerations

Who to Treat With TTVI?

How to Manage After TTVI?

Patient-Reported Outcomes are a True Measure of TTVI Value

CV Event Reduction is the Essential Criterion for Implementing New Device Therapies

TRISCEND II Trial: Transcatheter Valve Replacement vs. Optimal Medical Therapy for Severe Tricuspid Regurgitation

Transcatheter Tricuspid Valve Replacement - Lessons Learned From TRISCEND II

Transcatheter Tricuspid Edge-To-Edge-Repair – Updates from TRILUMINATE and TRI-FR

Real World TTVI Registries vs. Randomized Trials: Are the Outcomes Aligned?

TCT 984: Management of Right-Sided Vegetations With the AngioVac System: Single-Center Outcomes

TCT 983: Innovative Approach to Right Sided Endocarditis

TCT 982: The Safety of Catheter Aspiration of Tricuspid Valve Endocarditis Versus Open Surgery

How to Interpret Patient Reported Outcomes (PROs): Lessons from the Regulatory Approval Trials in TTVI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content